Showing results (1261-1270 of 1,274) with videos related to
Sort By:
Pageof 128
Parasites & Vectors|January 12, 2023
Evaluation of an open forecasting challenge to assess skill of West Nile virus neuroinvasive disease predictionKaren M Holcomb, Sarabeth Mathis, J Erin Staples, et al.Cell|June 11, 2024
Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assembliesNatasha I Edman, Ashish Phal, Rachel L Redler, et al.Nature Genetics|October 28, 2022
Adult human kidney organoids originate from CD24+ cells and represent an advanced model for adult polycystic kidney diseaseYaoxian Xu, Christoph Kuppe, Javier Perales-Patón, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell TransplantationAlex F Herrera, Matthew Mei, Lawrence Low, et al.Biorxiv : the Preprint Server for Biology|July 16, 2021
Multivalent designed proteins protect against SARS-CoV-2 variants of concernAndrew C Hunt, James Brett Case, Young-Jun Park, et al.Brain : a Journal of Neurology|August 4, 2025
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosisTomas Kalincik, Sifat Sharmin, Izanne Roos, et al.Science Translational Medicine|April 12, 2022
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in miceAndrew C Hunt, James Brett Case, Young-Jun Park, et al.The Lancet. Neurology|September 20, 2025
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteriaXavier Montalban, Christine Lebrun-Frénay, Jiwon Oh, et al.JAMA Neurology|July 12, 2023
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple SclerosisTomas Kalincik, Sifat Sharmin, Izanne Roos, et al.Journal of Immunological Methods|October 28, 2009
Neurofilament ELISA validationAxel Petzold, Ayse Altintas, Laura Andreoni, et al.Pageof 128